Sophia Genetics

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$15,853
$15,808
$15,779
$17,048
Gross Profit
10,654
10,776
10,405
11,899
EBITDA
-13,150
-12,995
-17,424
-22,071
EBIT
-15,363
-15,032
-19,483
-24,052
Net Income
-18,438
-15,193
-13,704
-24,061
Net Change In Cash
15,853
15,808
15,779
17,048
Free Cash Flow
-9,363
-11,501
-15,797
-13,193
Cash
95,787
105,396
103,735
123,251
Basic Shares
66,383
65,916
65,308
65,230

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$62,371
$47,560
$40,450
$28,400
Gross Profit
42,913
31,254
25,221
17,691
EBITDA
-70,700
-82,667
-70,837
-38,758
EBIT
-79,036
-88,238
-74,446
-41,148
Net Income
-78,981
-87,449
-73,675
-39,339
Net Change In Cash
62,371
47,560
40,450
28,400
Free Cash Flow
-57,801
-80,474
-64,610
-34,934
Cash
123,251
161,305
192,962
74,625
Basic Shares
64,750
64,099
63,857
63,857

Earnings Calls

Quarter EPS
2024-09-30
-$0.27
2024-06-30
-$0.23
2024-03-31
-$0.21
2023-12-31
-$0.37